Back to Steward Partners Investment Advisory, LLC Steward Partners Investment Advisory, LLC

ORMPORMP
Showing 8 of 27 quarters

Position history for Steward Partners Investment Advisory, LLCSteward Partners Investment Advisory, LLC's holdings in ORAMED PHARMACEUTICALS INC

Steward Partners Investment Advisory, LLC holds 8,826 shares of ORMP (ORAMED PHARMACEUTICALS INC), worth $42,453 as of 2026-Q2. ORMP represents 0.0% of Steward Partners Investment Advisory, LLC's portfolio.

Current Value

$42,453

Current Shares

8,826

Total Value Change

+$20,918

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
8,826
0.0%
$42,4530.0%$4.81
0
2026-Q1
Decreased
8,826
-4.8%
$30,0080.0%$3.38
0
2025-Q4
Increased
9,266
+5.0%
$26,4080.0%$2.62
20
2025-Q3
Unchanged
8,826
0.0%
$23,3010.0%$2.52
0
2025-Q2
Unchanged
8,826
0.0%
$19,8590.0%$2.00
0
2025-Q1
Unchanged
8,826
0.0%
$18,8880.0%$2.06
0
2024-Q4
Unchanged
8,826
0.0%
$21,3590.0%$2.17
0
2024-Q3
Unchanged
8,826
0.0%
$21,5350.0%$2.31
0

Other major holders of ORMP: BNP PARIBAS FINANCIAL MARKETS, MERCER GLOBAL ADVISORS INC /ADV, Invesco Ltd., MILLENNIUM MANAGEMENT LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used